SCHEMBL29415210

SCHEMBL29415210

CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 16/20 0.61
BACE2 Q9Y5Z0 2/20 0.61
CTSD P07339 2/20 0.61
NPY1R P25929 1/20 0.57
NPY2R P49146 1/20 0.57
NPY4R P50391 1/20 0.57
OPRK1 P41145 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31393817 0.99 BACE1 (0.62) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL30616041 0.97 OPRK1 (0.58) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL29659768 0.97 OPRK1 (0.58) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL17685569 0.96 BACE1 (0.58) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL30974493 0.95 BACE1 (0.54) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL29659734 0.94 BACE1 (0.59) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL29659764 0.94 BACE1 (0.59) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL17935594 0.93 BACE1 (0.57) BACE1BACE2CTSDNPY1RNPY2R
SCHEMBL5576870 0.93 OPRK1 (0.63) BACE1BACE2CTSDOPRK1
SCHEMBL5576866 0.93 OPRK1 (0.63) BACE1BACE2CTSDOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111494642-B Self-assembly material for in-situ construction of artificial extracellular matrix and preparation method and application thereof 国家纳米科学中心 2022-10-14 CN claimed
CN-110627912-B Bionic fiber network antibody self-assembly material and preparation method and application thereof 国家纳米科学中心 2022-03-08 CN claimed
US-20250262337-A1 METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA NORTHWESTERN UNIVERSITY 2025-08-21 US disclosed
CN-119499179-A Desemepin liposome targeting synovial fibroblasts and preparation method thereof 德阳市人民医院 2025-02-25 CN disclosed
CN-114805602-B Polypeptide nanomaterial for binding IgE and preparation method and application thereof 国家纳米科学中心 2024-04-23 CN disclosed
US-11643448-B2 Oxidized Aβ peptide JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2023-05-09 US disclosed
CN-111494642-B Self-assembly material for in-situ construction of artificial extracellular matrix and preparation method and application thereof 国家纳米科学中心 2022-10-14 CN disclosed
EP-4067370-A1 HIGH PENETRATION PRODRUG COMPOSITIONS OF PEPTIDES AND PEPTIDE RELATED COMPOUNDS Yu, Chongxi (US) 2022-10-05 EP disclosed
CN-114805602-A Polypeptide nano material for binding IgE, and preparation method and application thereof 国家纳米科学中心 2022-07-29 CN disclosed
CN-109942714-B Functional polypeptide and application 中国药科大学 2022-07-08 CN disclosed
CN-110627912-B Bionic fiber network antibody self-assembly material and preparation method and application thereof 国家纳米科学中心 2022-03-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250262337-A1 METHOD FOR DETECTING SOLUBLE OLIGOMERIC AMYLOID BETA APP, APBA1, APOB BACE1 5/4885BACE2 9/4885CTSD 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.